American Healthcare REIT - Q3 2026 Earnings Conference Call - AMERICAN HEALTHCARE REIT INC

Explicit Guidance:

• FY2026 Normalized FFO (NFFO) per diluted share raised to $2.23–$2.26, implying >30% growth versus 2025 (midpoint).
• FY2026 Total Portfolio Same-Store NOI Growth raised to 12–14% (midpoint up 100 bps).
• FY2026 Segment Same-Store NOI Growth: Trilogy (14.5–16.5%), Shop (23–26%), Outpatient Medical (0.5–1%), TripleNet (2.5–3.5%).
• FY2026 G&A guidance remains unchanged despite platform scaling.
• Q4 2026 implied same-store NOI growth expected to repeat Q3's ~28% performance (high 20s) based on revised annual guidance.

Business-Segment Outlook:

• Shop Segment: Targeting continued "revenue per occupied room" (REVPOR) acceleration; occupancy >90% driving pricing power with rent concessions reduced 34% YoY; aiming for sustained double-digit NOI growth via data analytics and revenue management.
• Trilogy Segment: Anticipating continued NOI growth via mix shifts to private pay and Medicare Advantage; non-same-store (new construction/expansions) expected to contribute 3–5 new campuses annually plus campus expansions on excess land; Kingston portfolio assets expected to enter same-store pool in 2027 to fuel growth.
• Portfolio Quality: Shop portfolio average vintage targeting newer assets (avg age 18.1 years, down from 22.9 years in 2025); focus on high-acuity, purpose-built AL/memory care in "fortress markets" with no near-term new supply.
• Outpatient Medical (OM): Net seller strategy ongoing; NOI contribution targeted to drop from ~35% to ~10% via selective dispositions; no core assets being added to OM.

Market and Competitive Outlook:

• Acquisition Pipeline: Awarded pipeline >$1 billion; portion expected to close in late Q4 2026, remainder in Q1 2027.
• Deal Flow: Expecting industry-wide transaction volume to remain at 2x 2025 levels in 2027; strong off-market flow from existing operator relationships allowing high selectivity.
• Pricing Power: Structural advantage in affluent, supply-constrained infill markets (e.g., LA, SF Bay, DC, NYC) where 5–9 year delivery timelines for new construction create barriers to entry.
• Competitive Advantage: Platform differentiation via "operator support ecosystem" (revenue management, AI, asset management bench) driving NOI outperformance (low double-digit over initial underwriting on 2025 acquisitions).

Macro / Industry Outlook:

• Demographics: Leveraging early-stage "Baby Boomer" demand surge expected to pressure occupancies higher and sustain rate growth for years.
• Regulation/Politics: Neutral to favorable outlook post-election; "split Congress and White House" viewed as maintaining business-as-usual for skilled nursing reimbursement and regulation, providing predictability for Trilogy.
• Market Dynamics: Shift in consumer preference toward larger units (1–2 bedrooms) and high amenity spaces; pricing metrics shifting from "price per unit" to "price per square foot" to reflect unit size and amenities.
• Supply Constraints: "Fortress markets" expected to remain supply-deficient for 5–9 years, protecting asset values and pricing power.

Strategic Initiatives:

• Organic Growth: Expansion of "ShopPlus" portfolio via data-driven revenue management and operational optimization; rolling out Trilogy revenue management playbook to broader operator roster.
• Talent & Tech: Integration of new Chief Technology Officer (John Crozier) to deploy AI, alternative data, and real-time operational dashboards; hiring of EVP Ann Lacey to lead asset management bench for "high-end consulting" on underperforming or top-tier assets.
• M&A/Partnerships: Continued "measured aggression" strategy: prioritizing existing operator relationships to de-risk growth; targeting $2.1 billion+ in closed deals (2019+ vintage) with pipeline to close through early 2027.
• Capital Allocation: Maintaining strict "match-funded" discipline for all acquisitions using unsettled forward sale proceeds and credit lines; no immediate plans for new equity raises as pipeline is fully funded.
• Dispositions: Opportunistic sales of non-core OM assets; potential for early 2027 announcements on older asset sales or micro-market vulnerability disposals.

Risks and Headwinds to Outlook:

• Operator Capacity: Risk of "spreading too thin" if growth outpaces operator capabilities; mitigation via intentional scaling aligned with operator bench depth.
• Regulatory Changes: Monitoring state-level healthcare regulations; split Congress provides baseline stability, but local state-level shifts remain a risk.
• Cost Pressures: Expense growth vs. revenue growth; managed via controlled cost reductions (e.g., employee benefits optimization) and operational efficiency.
• Financing: Floating rate exposure; mitigated by swapping in Oct 2026 to hedge Jan 2027 maturities (term loan and existing swaps).
• Execution Risk: Reliance on "quality of care" driving occupancy and pricing; failure in care delivery would erode trust and financial performance.

Management Tone on the Future:

• Confidence Level: Highly confident in "platform effect" driving compounding growth; describes strategy as "proven" and "working" with 11 consecutive quarters of double-digit same-store NOI growth.
• Stance: "Measured aggression"; willing to move decisively on quality assets but patient on price; emphasizes that "sector tailwinds are not the AHR advantage, our platform and execution is."
• Comparative Outlook: Expects 2027 to maintain high growth rates (Q4 implied ~28% same-store NOI growth); views current cycle as "early" in the demographic opportunity.
• Change vs. Prior: Upgraded guidance for FY2026 NFFO and Same-Store NOI; maintained G&A guidance to signal efficiency; clarified that current pipeline is not reflected in guidance.

Miscellaneous:

• Balance Sheet: Net debt to EBITDA 1.9x at quarter end; $1.3 billion gross proceeds available from forward sales; $850 million credit line capacity.
• Valuation Metrics: Initial stabilized yields mid-5% to mid-6%; first-year yields above 7%; all acquisitions priced below replacement cost.
• Leadership Changes: Eric Chang (CFO, ex-Public Storage) joined Oct 1; Brian Pay retired Sep 30; new CTO and EVP appointed for asset management/tech.
• Kensington/LCB Deals: Establishing long-term partnerships with key operators; Kensington transaction includes 6 closed assets ($572M) with 2 remaining to close year-end; LCB deal establishes Northeast footprint.